Esophageal Toxicity From High-Dose, Single-Fraction Paraspinal Stereotactic Radiosurgery

被引:78
作者
Cox, Brett W. [1 ]
Jackson, Andrew [2 ]
Hunt, Margie [2 ]
Bilsky, Mark [3 ]
Yamada, Yoshiya [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, Div Neurosurg, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med Phys, Div Neurosurg, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Neurosurg, New York, NY 10065 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 83卷 / 05期
关键词
Spine radiosurgery; Esophageal toxicity; Paraspinal SBRT; IGRT; Spine tumors; SPINAL METASTASES; RADIATION TREATMENT; RADIOTHERAPY; PREDICTORS; LESIONS; CANCER;
D O I
10.1016/j.ijrobp.2012.01.080
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To report the esophageal toxicity from single-fraction paraspinal stereotactic radiosurgery (SRS) and identify dosimetric and clinical risk factors for toxicity. Methods and Materials: A total of 204 spinal metastases abutting the esophagus (182 patients) were treated with high-dose single-fraction SRS during 2003-2010. Toxicity was scored using the National Cancer Institute Common Toxicity Criteria for Adverse Events, version 4.0. Dose-volume histograms were combined to generate a comprehensive atlas of complication incidence that identifies risk factors for toxicity. Correlation of dose-volume factors with esophageal toxicity was assessed using Fisher's exact test and logistic regression. Clinical factors were correlated with toxicity. Results: The median dose to the planning treatment volume was 24 Gy. Median follow-up was 12 months (range, 3-81). There were 31 (15%) acute and 24 (12%) late esophageal toxicities. The rate of grade >= 3 acute or late toxicity was 6.8% (14 patients). Fisher's exact test resulted in significant median splits for grade >= 3 toxicity at V12 = 3.78 cm(3) (relative risk [RR] 3.7, P=.05), V15 Z= 1.87 cm3 (RR 13, P=.0013), V20 = 0.11 cm(3) (RR 6, P=0.01), and V22 = 0.0 cm(3) (RR 13, P=. 0013). The median split for D2.5 cm(3) (14.02 Gy) was also a significant predictor of toxicity (RR 6; P=. 01). A highly significant logistic regression model was generated on the basis of D2.5 cm(3). One hundred percent (n=7) of grade >= 4 toxicities were associated with radiation recall reactions after doxorubicin or gemcitabine chemotherapy or iatrogenic manipulation of the irradiated esophagus. Conclusions: High-dose, single-fraction paraspinal SRS has a low rate of grade >= 3 esophageal toxicity. Severe esophageal toxicity is minimized with careful attention to esophageal doses during treatment planning. Iatrogenic manipulation of the irradiated esophagus and systemic agents classically associated with radiation recall reactions are associated with development of grade >= 4 toxicity. (C) 2012 Elsevier Inc.
引用
收藏
页码:E661 / E667
页数:7
相关论文
共 50 条
  • [21] Radiation-Induced Edema After Single-Fraction or Multifraction Stereotactic Radiosurgery for Meningioma: A Critical Review
    Milano, Michael T.
    Sharma, Manju
    Soltys, Scott G.
    Sahgal, Arjun
    Usuki, Kenneth Y.
    Saenz, Jon-Michael
    Grimm, Jimm
    El Naqa, Issam
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (02): : 344 - 357
  • [22] A multi-center analysis of single-fraction versus hypofractionated stereotactic radiosurgery for the treatment of brain metastasis
    Remick, Jill S.
    Kowalski, Emily
    Khairnar, Rahul
    Sun, Kai
    Morse, Emily
    Cherng, Hua-Ren R.
    Poirier, Yannick
    Lamichhane, Narottam
    Becker, Stewart J.
    Chen, Shifeng
    Patel, Akshar N.
    Kwok, Young
    Nichols, Elizabeth
    Mohindra, Pranshu
    Woodworth, Graeme F.
    Regine, William F.
    Mishra, Mark, V
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [23] NEAR-COMPLETE PATHOLOGICAL RESPONSE OF CHORDOMA TO HIGH-DOSE SINGLE-FRACTION RADIOTHERAPY: CASE REPORT
    Wu, Abraham J.
    Bilsky, Mark H.
    Edgar, Mark A.
    Yamada, Yoshiya
    NEUROSURGERY, 2009, 64 (02) : 389 - 390
  • [24] Treatment outcomes of single-fraction stereotactic radiosurgery for adenoid cystic carcinoma: a case series of 55 patients
    Hong, Sukwoo
    Garces, Yolanda I.
    Price, Katharine A.
    Shinya, Yuki
    Parney, Ian F.
    Link, Michael J.
    Pollock, Bruce E.
    JOURNAL OF NEURO-ONCOLOGY, 2024, 166 (02) : 369 - 376
  • [25] Feasibility of a Single-Fraction Stereotactic Dose of 30 Gy to Solitary Lung Lesions on Halcyon
    Misa, Joshua
    Knight, James A.
    Pokhrel, Damodar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [26] Comparison of Gonadal Toxicity of Single-Fraction Ultra-High Dose Rate and Conventional Radiation in Mice
    Cuitino, Maria C.
    Fleming, Jessica L.
    Jain, Sagarika
    Cetnar, Ashley
    Ayan, Ahmet S.
    Woollard, Jeffrey
    Manring, Heather
    Meng, Wei
    Mcelroy, Joseph P.
    Blakaj, Dukagjin M.
    Gupta, Nilendu
    Chakravarti, Arnab
    ADVANCES IN RADIATION ONCOLOGY, 2023, 8 (04)
  • [27] High-Dose, Single-Fraction Irradiation Rapidly Reduces Tumor Vasculature and Perfusion in a Xenograft Model of Neuroblastoma
    Jani, Ashish
    Shaikh, Fauzia
    Barton, Sunjay
    Willis, Callen
    Banerjee, Debarshi
    Mitchell, Jason
    Hernandez, Sonia L.
    Hei, Tom
    Kadenhe-Chiweshe, Angela
    Yamashiro, Darrell J.
    Connolly, Eileen P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (05): : 1173 - 1180
  • [28] Disparities in the Use of Single-fraction Stereotactic Radiosurgery for the Treatment of Brain Metastases From Non-small Cell Lung Cancer
    Modh, Ankit
    Doshi, Abhishek
    Burmeister, Charlotte
    Elshaikh, Mohamed A.
    Lee, Ian
    Shah, Mira
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (02)
  • [29] Hypofractionated versus single-fraction stereotactic radiosurgery for the treatment of brain metastases: A systematic review and meta-analysis
    July, Julius
    Pranata, Raymond
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 206
  • [30] Single-fraction versus hypofractionated stereotactic radiosurgery for medium-sized brain metastases of 2.5 to 3 cm
    Chon, Haemin
    Yoon, KyoungJun
    Lee, Doheui
    Kwon, Do Hoon
    Cho, Young Hyun
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (01) : 49 - 56